Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 2,179 shares at $98.38 ($215K) on 2014-02-03, disclosed to the SEC on 2014-02-04.
Scheduled sale ($215k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.38 | 1,779 | $175K | 81.6% |
| 2 | $98.90 | 400 | $40K | 18.4% |
| Total | $98.48 avg | 2,179 | $215K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |